BridgeBio Spins Out Cancer Arm With $200m Fundraise

Spinout
BridgeBio will narrow focus and reduce cash-burn with cancer spinout • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business